We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M Turnover 0%
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
+19.95%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$215M
Cap. Flow
+$22.3M
Cap. Flow %
1.61%
Top 10 Hldgs %
99.31%
Holding
15
New
–
Increased
2
Reduced
–
Closed
–
Avg Time Held
3.8 years
Top 10 Avg Time Held
3.2 years
Top 20 Avg Time Held
3.8 years

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$17.2M
2
AQB icon
AquaBounty Technologies
AQB
+$5.05M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.84%
2 Energy 3.55%
3 Consumer Staples 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PGEN icon
1
Precigen
PGEN
$2.38B
$907M 65.66%
59,132,705
+1,204,416
+2% +$17.2M
2013 Q3
18 quarters
HALO icon
2
Halozyme
HALO
$13.9B
$345M 24.96%
17,592,771
– –
2013 Q2
19 quarters
TCRT icon
3
Alaunos Therapeutics
TCRT
$7.95M
$38.1M 2.76%
64,731
– –
2013 Q2
19 quarters
EPD icon
4
Enterprise Products Partners
EPD
$79.5B
$27.8M 2.01%
1,135,734
– –
2013 Q2
19 quarters
AQB icon
5
AquaBounty Technologies
AQB
$5.35M
$22.2M 1.61%
376,915
+76,923
+26% +$5.05M
2017 Q1
4 quarters
ET icon
6
Energy Transfer Partners
ET
$69.2B
$12M 0.87%
847,650
– –
2013 Q2
19 quarters
OCGN icon
7
Ocugen
OCGN
$267M
$7.4M 0.54%
44,843
– –
2014 Q4
13 quarters
FCSC
8
DELISTED
Fibrocell Science Inc.
FCSC
$4.88M 0.35%
1,653,483
– –
2013 Q2
19 quarters
TOVX icon
9
Theriva Biologics
TOVX
$9.39M
$4.22M 0.31%
1,513
– –
2013 Q2
19 quarters
TCP
10
DELISTED
TC Pipelines LP
TCP
$3.36M 0.24%
97,000
– –
2013 Q2
19 quarters
NS icon
11
DELISTED
NuStar Energy L.P.
NS
$2.96M 0.21%
145,200
– –
2013 Q2
19 quarters
ETP
12
DELISTED
Energy Transfer Partners, L.P.
ETP
$2.87M 0.21%
176,828
– –
2017 Q2
3 quarters
OGEN icon
13
Oragenics
OGEN
$1.9M
$2.69M 0.2%
860
– –
2013 Q2
19 quarters
PRPO icon
14
Precipio
PRPO
$39.2M
$730K 0.05%
4,530
– –
2017 Q2
3 quarters
TPST icon
15
Tempest Therapeutics
TPST
$10.1M
$303K 0.02%
128
– –
2013 Q4
17 quarters

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q1 2018 Portfolio in Review

As of Q1 2018, Third Security held 15 positions worth $1.38B, up 18% from $1.17B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 0%. Third Security opened no new positions and made no exits, leaving the 15-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier, followed by Energy and Consumer Staples.

  • Third Security added most to Precigen in Q1 2018, an estimated $17.2M increase.
  • Third Security's ten largest holdings make up 99% of its $1.38B portfolio in Q1 2018.
  • Third Security opened 0 new positions and closed 0 in Q1 2018.
  • Third Security's portfolio value rose 18% quarter-over-quarter to $1.38B.

Based on Third Security's 13F filing for Q1 2018, filed 1 May 2018.